N-glycosylation profiling of serum immunoglobulin in opisthorchiasis patients.

[1]  G. Alter,et al.  Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases , 2020, Glycobiology.

[2]  M. Collin Antibody glycosylation as an immunological key in health and disease , 2020, Glycobiology.

[3]  K. Schug,et al.  Supercharging and multiple reaction monitoring of high-molecular-weight intact proteins using triple quadrupole mass spectrometry. , 2019, Rapid communications in mass spectrometry : RCM.

[4]  A. Suwannatrai,et al.  Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand , 2019, Infectious Diseases of Poverty.

[5]  Chuncui Huang,et al.  Distribution of abnormal IgG glycosylation patterns from rheumatoid arthritis and osteoarthritis patients by MALDI-TOF-MSn. , 2019, The Analyst.

[6]  S. Targan,et al.  Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases. , 2018, Gastroenterology.

[7]  G. Vidarsson,et al.  Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases , 2018, Front. Immunol..

[8]  P. Brindley,et al.  Update on Pathogenesis of Opisthorchiasis and Cholangiocarcinoma. , 2018, Advances in parasitology.

[9]  Jun-Tao Ji,et al.  N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma , 2017, BMC Cancer.

[10]  P. Brindley,et al.  Parasite Infection, Carcinogenesis and Human Malignancy , 2016, EBioMedicine.

[11]  Yi‐Chen Wang,et al.  Uncovering the Pathogenic Landscape of Helminth (Opisthorchis viverrini) Infections: A Cross-Sectional Study on Contributions of Physical and Social Environment and Healthcare Interventions , 2016, PLoS neglected tropical diseases.

[12]  L. R. Ruhaak,et al.  Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients. , 2016, Journal of proteome research.

[13]  R. Ubink,et al.  A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA , 2016, mAbs.

[14]  L. R. Ruhaak,et al.  A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins. , 2015, Journal of proteome research.

[15]  Y. Liu,et al.  Ovarian cancer transformation from adenocarcinoma to undifferentiated small cell carcinoma: A case report. , 2015, Oncology letters.

[16]  J. Koomen,et al.  Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease. , 2015, Journal of proteomics.

[17]  O. Mayboroda,et al.  Clinical Severity of Visceral Leishmaniasis Is Associated with Changes in Immunoglobulin G Fc N-Glycosylation , 2014, mBio.

[18]  S. Hartmann,et al.  Filariasis asymptomatically infected donors have lower levels of disialylated IgG compared to endemic normals , 2014, Parasite immunology.

[19]  Gillian Dekkers,et al.  IgG Subclasses and Allotypes: From Structure to Effector Functions , 2014, Front. Immunol..

[20]  K. Brorson,et al.  Post-translational structural modifications of immunoglobulin G and their effect on biological activity , 2014, Analytical and Bioanalytical Chemistry.

[21]  R. Andrews,et al.  The zoonotic, fish-borne liver flukes Clonorchis sinensis, Opisthorchis felineus and Opisthorchis viverrini. , 2013, International journal for parasitology.

[22]  B. Verrier,et al.  Dectin-1 Is Essential for Reverse Transcytosis of Glycosylated SIgA-Antigen Complexes by Intestinal M Cells , 2013, PLoS biology.

[23]  C. Lebrilla,et al.  Absolute quantitation of immunoglobulin G and its glycoforms using multiple reaction monitoring. , 2013, Analytical chemistry.

[24]  M. Ehlers,et al.  The carbohydrate switch between pathogenic and immunosuppressive antigen‐specific antibodies , 2013, Experimental dermatology.

[25]  A. Loukas,et al.  The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer. , 2012, Trends in parasitology.

[26]  H. Bartsch,et al.  Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. , 2012, Parasitology international.

[27]  S. Pinlaor,et al.  Specific serum IgG, but not IgA, antibody against purified Opisthorchis viverrini antigen associated with hepatobiliary disease and cholangiocarcinoma. , 2012, Parasitology international.

[28]  L. Cavacini,et al.  Structure and function of immunoglobulins. , 2010, The Journal of allergy and clinical immunology.

[29]  Pauline M. Rudd,et al.  Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis , 2009, Disease markers.

[30]  R. Aebersold,et al.  Selected reaction monitoring for quantitative proteomics: a tutorial , 2008, Molecular systems biology.

[31]  Eva Acosta-Rodriguez,et al.  Polyclonal B cell activation in infections: infectious agents’ devilry or defense mechanism of the host? , 2007, Journal of Leukocyte Biology.

[32]  M. Itoh,et al.  The ELISA-based detection of anti-Opisthorchis viverrini IgG and IgG4 in samples of human urine and serum from an endemic area of north–eastern Thailand , 2007, Annals of tropical medicine and parasitology.

[33]  Banchob Sripa,et al.  Liver Fluke Induces Cholangiocarcinoma , 2007, PLoS medicine.

[34]  Pauline M Rudd,et al.  The impact of glycosylation on the biological function and structure of human immunoglobulins. , 2007, Annual review of immunology.

[35]  J. Waikagul,et al.  Serodiagnosis of human opisthorchiasis using cocktail and electroeluted Bithynia snail antigens. , 2002, Parasitology international.

[36]  I. Mackay,et al.  The immunobiology of bile and biliary epithelium , 1999, Hepatology.

[37]  H. Bartsch,et al.  Relationships between the synthesis of N-nitrosodimethylamine and immune responses to chronic infection with the carcinogenic parasite, Opisthorchis viverrini, in men. , 1998, Carcinogenesis.

[38]  D. Bunnag,et al.  Egg-negative residents of an Opisthorchiasis-endemic area possess high levels of anti-Opisthorchis antibodies. , 1995, Advances in experimental medicine and biology.

[39]  C. Pairojkul,et al.  Association of antibodies to Opisthorchis viverrini with hepatobiliary disease in northeastern Thailand. , 1994, The American journal of tropical medicine and hygiene.

[40]  D. Bunnag,et al.  Possible protective immunity in human opisthorchiasis , 1994, Parasite immunology.

[41]  M. Haswell-Elkins,et al.  Immune responsiveness and parasite‐specific antibody levels in human hepatobiliary disease associated with Opisthorchis viverrini infection , 1991, Clinical and experimental immunology.

[42]  G. Doungchawee,et al.  A characteristic immunoblotting pattern for Opisthorchiasis sera with metacercarial antigens. , 1988, Clinical and experimental immunology.

[43]  D. Bunnag,et al.  Characterization of humoral immune response in the serum and bile of patients with opisthorchiasis and its application in immunodiagnosis. , 1988, The American journal of tropical medicine and hygiene.

[44]  V. Viyanant,et al.  Enzyme-linked immunosorbent assay for detection of Opisthorchis viverrini infection. , 1985, The Southeast Asian journal of tropical medicine and public health.